Asthma can cause excess mucus buildup in the lungs, leading to chest congestion. It usually worsens when you have a respiratory infection or when your allergies are acting up. However, you can also ...

Combination meds with an ICS and LABA option to relax and open airways, like Advair (fluticasone with salmeterol) Long-acting muscarinic agonists (LAMA) drugs, including Spiriva Respimat (tiotropium ...

Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...

1 Day HKMPY -0.46% DJIA 0.52% S&P 500 0.11% Health Care/Life Sciences 0.39% ...

GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...

First in his series is venture capitalists Hikma Ventures’ managing director, Lana Ghanem. I think technology's biggest influence will be felt in both disease prevention and personalised medicine.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Shares of Hikma Pharmaceuticals PLC HIK inched up 0.05% to £19.89 Tuesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.42% ...

Hikma’s US subsidiary ... The two companies have already partnered to produce VR315, a generic version of GSK’s Advair/Seretide (fluticasone+salmeterol), and VR506, a generic, inhaled ...